This site uses cookies. By using this site you agree to receiving cookies. View Policy.

106%
Raised
£212,480
Investors
187
Target
£200,000
Equity
6.46%
Pre-money valuation
£3,075,000

Airmony is a new sleep apnea device. Portable, light and tubeless, Airmony pushes a continuous flow of air to help sleep apnea patients breathe and enjoy a good night’s sleep. It includes sensors for e-health tech, allowing patients and their doctors to monitor sleep patterns.

  • Aiming to be the first tubeless device, portable & USB battery-powered
  • E-Health compatible for self-monitoring or to connect with your doctor
  • Approx 20m people diagnosed with sleep apnea across the U.S and Europe
  • Market growing at 7.8% CAGR – All competitors are tabletop

Idea

Obstructive Sleep Apnea (OSAS) is a common sleep disorder where breathing stops for a few seconds during sleep. It affects up to 6% of the world’s adult population; mostly men, but also women, children and even athletes. Untreated, moderate to severe OSAS can lead to serious health complications, such as heart disease, stroke, diabetes, cancer and depression.

Continuous Positive Airway Pressure (CPAP) devices exist to treat this condition, but our research suggests that 98% are clunky, intrusive, table top versions. Airmony is a new CPAP device – it’s smaller, lighter, tubeless, washable and can be used both by children and adults.

With its low noise level, Airmony is discreet but effective and it runs for more than two nights on a USB rechargeable battery. It also includes sensors for e-health monitoring, allowing both patients and their doctor to review sleep patterns.

Airmony’s development is supported by numerous institutions, including the Estivill Sleep Foundation, founded by renowned sleep specialist, Dr. Eduard Estivill.

We aim to operate with a hybrid model, through distributors and online direct sales, alongside our app, which is currently in development. The sleep apnea devices market is growing at a CAGR of 7.8%, and the total addressable market is projected to be worth $6.49bn by 2023.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Airmony pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.